TSHZ3 and ovarian carcinoma: Additionally, Affymetrix SNP 6.0 data obtained from the TCGA ovarian cancer study (see Methods) was also evaluated for independent breakpoints affecting TSHZ3 in the absence of CCNE1 amplification.